Fact.MR projects the global preimplantation genetic testing market to ascend at around 9% CAGR during the forecast period of 2021 to 2031, according to a recently published report. Increasing number of people suffering from genetic diseases due changing lifestyles has heightened growth prospects.
Historically, the market expanded at around 8% CAGR, reaching a valuation of almost US$ 550 Mn in 2020. Healthcare providers and institutions are highly considering preimplantation genetic testing to identify defects present in embryos before implantation.
Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=292
The biggest benefit offered by preimplantation testing is it offers an opportunity to conceive a pregnancy unaffected by genetic conditions. Researchers and healthcare institutes are trying to find new methods and techniques using the latest technology to minimize various risks associated with preimplantation genetic testing.
Key Takeaways from Market Study
- Global demand for genetic screening to gain 2/3rd market share through 2031.
- Maximum application found in embryo HLA typing for stem cell therapy, yielding 40% revenue.
- North America remains the highest consumer, contributing a CAGR of around 7%
- U.K contributing to the bulk of preimplantation genetic testing market expansion, growing at a CAGR of 8%
- India and China to collectively generate around 60% of demand across Asia through 2031
- NGS is likely to emerge as the most popular technology, surpassing US$ 200 Mn in revenue
“Prominent service providers are capitalizing on the broadening scope of preimplantation genetic testing in infant and prenatal care to ascertain presence of Down syndrome, heightening expansion prospects,” remarks a Fact.MR analyst.
Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=292
Competitive Landscape
The report has also profiled leading players in the global market for preimplantation genetic testing. These include companies such as Abbott Laboratories, Agilent Technologies Inc., CooperSurgical Inc., Illumina, Inc., Oxford Gene Technology IP, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Natera, Inc., CombiMatrix Corporation, Rubicon Genomics, Inc., and Genea Limited.
Companies leverage strategic collaborative initiatives to increase their market share and profitability. They are also acquiring start-ups working on technologies to strengthen their product capabilities.
- For instance, in 2021, United and Abbott announced a collaboration to use Abbott’s BinaxNOW™ COVID-19 Home Test and Abbott’s NAVICA app to help make the international travel experience more seamless.
The CDC guidelines permit travelers to self-administer a rapid antigen test under the real-time supervision of a telehealth service and use the verified negative test result to board an international flight to the U.S. if they test negative.
Get More Insights- https://www.biospace.com/article/preimplantation-genetic-testing-demand-to-grow-by-9-percent-cagr-annually-through-2031/
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the preimplantation genetic testing market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031.
In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of test type (Genetic Diagnosis and Genetic Screening), application (embryo HLA typing for stem cell therapy, IVF prognosis, late-onset genetic disorders, inherited genetic disease and other applications), technology (NGS, PCR, FISH, CGH, and SNP) and end-use industry (hospitals, diagnostic labs, research & academic institutes, specialized clinics, and other end users), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).
Explore Fact.MR’s Coverage on the Healthcare Domain
Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.
Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.
Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight:https://www.factmr.com/report/292/preimplantation-genetic-testing-market
Press Release: https://www.factmr.com/media-release/2130/global-preimplantation-genetic-testing-trends
